DrugPatentWatch Database Preview
Bionpharma Inc Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for BIONPHARMA INC, and what generic alternatives to BIONPHARMA INC drugs are available?
BIONPHARMA INC has thirty-seven approved drugs.
There are four US patents protecting BIONPHARMA INC drugs.
There are ten patent family members on BIONPHARMA INC drugs in thirteen countries and forty-one supplementary protection certificates in twelve countries.
Summary for Bionpharma Inc
| International Patents: | 10 |
| US Patents: | 4 |
| Tradenames: | 35 |
| Ingredients: | 31 |
| NDAs: | 37 |
| Drug Master File Entries: | 2 |
| Patent Litigation for Bionpharma Inc: | See patent lawsuits for Bionpharma Inc |
Drugs and US Patents for Bionpharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bionpharma Inc | PARICALCITOL | paricalcitol | CAPSULE;ORAL | 202539-002 | Mar 27, 2014 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Bionpharma Inc | BENZONATATE | benzonatate | CAPSULE;ORAL | 081297-001 | Jan 29, 1993 | AA | RX | No | No | Start Trial | Start Trial | ||||
| Bionpharma Inc | CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | CAPSULE;ORAL | 022429-004 | Jul 23, 2009 | OTC | Yes | Yes | Start Trial | Start Trial | |||||
| Bionpharma Inc | ETHOSUXIMIDE | ethosuximide | CAPSULE;ORAL | 040430-001 | Oct 28, 2002 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Bionpharma Inc | STAVZOR | valproic acid | CAPSULE, DELAYED RELEASE;ORAL | 022152-001 | Jul 29, 2008 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Bionpharma Inc | LOPERAMIDE HYDROCHLORIDE | loperamide hydrochloride | CAPSULE;ORAL | 021855-001 | Aug 4, 2005 | OTC | Yes | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Bionpharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bionpharma Inc | MIDOL LIQUID GELS | ibuprofen | CAPSULE;ORAL | 021472-001 | Oct 18, 2002 | 6,251,426 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Bionpharma Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 102940887 | Start Trial |
| European Patent Office | 3061447 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2006096580 | Start Trial |
| Canada | 2600023 | Start Trial |
| Denmark | 1863458 | Start Trial |
| Mexico | 2007011039 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Bionpharma Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0984957 | CR 2012 00035 | Denmark | Start Trial | PRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105 |
| 0984957 | PA2011005 | Lithuania | Start Trial | PRODUCT NAME: NAPROXENUM + ESOMEPRAZOLUM; REGISTRATION NO/DATE: LT/1/10/2302/001-LT/1/10/2302/012 20110126 |
| 0637297 | SPC/GB01/041 | United Kingdom | Start Trial | SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB01/041 GRANTED TO EISAI R + D MANAGEMENT., LTD. IN RESPECT OF THE PRODUCT BEXAROTENE (4-(1-(3, 5, 5, 8, 8-PENTAMETHYL-5, 6, 7, 8-TETRAHYDRO-2-NAPHTHALENYL)VINYL)BENZOIC ACID), WHICH WAS ADVERTISED AS COMING INTO FORCE IN JOURNAL NO 6469 DATED 15/05/2013 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, IT WILL EXPIRE ON 01/04/2016. |
| 0152897 | SPC/GB01/012 | United Kingdom | Start Trial | PRODUCT NAME: DESLORATADINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/157/001-013 20010115; UK EU/1/00/158/001-013 20010115; UK EU/1/00/159/001-013 20010115; UK EU/1/00/160/001-013 20010115; UK EU/1/00/161/001-013 20010115 |
| 0113964 | 97C0037 | Belgium | Start Trial | PRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826 |
| 1411900 | 1190013-1 | Sweden | Start Trial | PRODUCT NAME: NAPROXEN OCH ESOMEPRAZOL; NAT. REG. NO/DATE: MTNR 43248 20101203; FIRST REG.: GB PL 17901/0263 20101105 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
